Advertisement
U.S. markets closed
Advertisement

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
28.78+0.15 (+0.52%)
At close: 04:00PM EST
28.77 -0.01 (-0.03%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Performance Outlook
Previous Close28.63
Open28.65
Bid28.76 x 2900
Ask28.77 x 4000
Day's Range28.59 - 28.97
52 Week Range28.30 - 54.93
Volume27,714,307
Avg. Volume31,405,728
Market Cap162.504B
Beta (5Y Monthly)0.56
PE Ratio (TTM)15.73
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.64 (5.70%)
Ex-Dividend DateNov 09, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pfizer, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    9 days agoMorningstar
View more
  • Insider Monkey

    12 Healthcare Stocks Billionaires Like the Most

    In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]

  • BioPharma Dive

    ASH23: CAR-T for autoimmune disease, real-world questions and sickle cell’s social media mentions

    Study results disclosed at the American Society of Hematology meeting Saturday suggested potential for cell therapy in lupus and pointed out drug trial limitations.

  • Motley Fool

    3 Dividend Stocks Trading at 52-Week Lows

    I have always stated that stocks should not be bought just because they trade at a 52-week low. A new 52-week low does not make a particular stock cheap. In today's video I will look at three dividend stocks trading at their 52-week lows and examine their metrics to determine if the stock is cheap or not.